BioCentury | Sep 15, 2020
Deals

With $1.7B in Merck deals, Seattle Genetics plots broader pipeline

...gained Tukysa through its 2018 acquisition of Cascadian Therapeutics Inc....
BioCentury | Oct 21, 2019
Clinical News

Seattle Genetics at all-time high on strength of breast cancer readout

...class. The gains are more than three times the amount Seattle Genetics paid to acquire Cascadian Therapeutics Inc....
BioCentury | Sep 30, 2019
Clinical News

Seattle Genetics, Astellas ADC posts strong response in bladder combo study at ESMO

...tucatinib to treat HER2-amplified metastatic colorectal cancer, which it gained via its 2018 acquisition of Cascadian Therapeutics...
BioCentury | Sep 27, 2019
Clinical News

Seattle Genetics gains on Phase II mCRC data from Cascadian candidate

...metastatic colorectal cancer, marking the first sign of fruit from its $614 million acquisition of Cascadian Therapeutics...
BioCentury | May 11, 2019
Product Development

Now grown up, independent biotechs bulk up their platforms with more modalities

...2018, the biotech took its most ambitious step outside of ADCs to date, by acquiring Cascadian Therapeutics Inc....
BioCentury | Sep 19, 2018
Company News

Management tracks: GSK adds Corsico, Enzmann to chair CHMP

...CFO and CBO. Myers was president and CEO, and Eastland was CFO and CBO at Cascadian Therapeutics Inc....
BioCentury | Apr 25, 2018
Company News

Management tracks: Urovant, Cue

...company Nohla Therapeutics Inc. (Seattle, Wash.) hired Gary Christianson as COO. He was COO at Cascadian Therapeutics Inc....
BioCentury | Apr 6, 2018
Finance

Picking season

...Astellas Pharma Inc. (Tokyo:4503) Universal Cells Inc. 2/13/18 ND ND $102.5 Seattle Genetics Inc. (NASDAQ:SGEN) Cascadian Therapeutics Inc....
BioCentury | Feb 2, 2018
Financial News

Seattle Genetics prices $690M follow-on

...acquisition of cancer company Cascadian Therapeutics Inc. (NASDAQ:CASC), announced Jan. 31. Seattle Genetics Inc. (NASDAQ:SGEN), Bothell, Wash. Jennie Walters Cascadian Therapeutics Inc. Seattle...
BioCentury | Feb 2, 2018
Company News

Seattle Genetics buying Cascadian for $614M

...Seattle Genetics Inc. (NASDAQ:SGEN) said it will acquire cancer company Cascadian Therapeutics Inc. (NASDAQ:CASC) for $10 per share...
...Canada. Seattle Genetics Inc. (NASDAQ:SGEN), Bothell, Wash. Cascadian Therapeutics Inc. (NASDAQ:CASC), Seattle, Wash. Business: Oncology Jennie Walters Adcetris brentuximab vedotin CASC-578 tucatinib Array BioPharma Cascadian Therapeutics Inc. Seattle...
Items per page:
1 - 10 of 442
BioCentury | Sep 15, 2020
Deals

With $1.7B in Merck deals, Seattle Genetics plots broader pipeline

...gained Tukysa through its 2018 acquisition of Cascadian Therapeutics Inc....
BioCentury | Oct 21, 2019
Clinical News

Seattle Genetics at all-time high on strength of breast cancer readout

...class. The gains are more than three times the amount Seattle Genetics paid to acquire Cascadian Therapeutics Inc....
BioCentury | Sep 30, 2019
Clinical News

Seattle Genetics, Astellas ADC posts strong response in bladder combo study at ESMO

...tucatinib to treat HER2-amplified metastatic colorectal cancer, which it gained via its 2018 acquisition of Cascadian Therapeutics...
BioCentury | Sep 27, 2019
Clinical News

Seattle Genetics gains on Phase II mCRC data from Cascadian candidate

...metastatic colorectal cancer, marking the first sign of fruit from its $614 million acquisition of Cascadian Therapeutics...
BioCentury | May 11, 2019
Product Development

Now grown up, independent biotechs bulk up their platforms with more modalities

...2018, the biotech took its most ambitious step outside of ADCs to date, by acquiring Cascadian Therapeutics Inc....
BioCentury | Sep 19, 2018
Company News

Management tracks: GSK adds Corsico, Enzmann to chair CHMP

...CFO and CBO. Myers was president and CEO, and Eastland was CFO and CBO at Cascadian Therapeutics Inc....
BioCentury | Apr 25, 2018
Company News

Management tracks: Urovant, Cue

...company Nohla Therapeutics Inc. (Seattle, Wash.) hired Gary Christianson as COO. He was COO at Cascadian Therapeutics Inc....
BioCentury | Apr 6, 2018
Finance

Picking season

...Astellas Pharma Inc. (Tokyo:4503) Universal Cells Inc. 2/13/18 ND ND $102.5 Seattle Genetics Inc. (NASDAQ:SGEN) Cascadian Therapeutics Inc....
BioCentury | Feb 2, 2018
Financial News

Seattle Genetics prices $690M follow-on

...acquisition of cancer company Cascadian Therapeutics Inc. (NASDAQ:CASC), announced Jan. 31. Seattle Genetics Inc. (NASDAQ:SGEN), Bothell, Wash. Jennie Walters Cascadian Therapeutics Inc. Seattle...
BioCentury | Feb 2, 2018
Company News

Seattle Genetics buying Cascadian for $614M

...Seattle Genetics Inc. (NASDAQ:SGEN) said it will acquire cancer company Cascadian Therapeutics Inc. (NASDAQ:CASC) for $10 per share...
...Canada. Seattle Genetics Inc. (NASDAQ:SGEN), Bothell, Wash. Cascadian Therapeutics Inc. (NASDAQ:CASC), Seattle, Wash. Business: Oncology Jennie Walters Adcetris brentuximab vedotin CASC-578 tucatinib Array BioPharma Cascadian Therapeutics Inc. Seattle...
Items per page:
1 - 10 of 442